MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krieter, P. A.
Right arrow Articles by Burk, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krieter, P. A.
Right arrow Articles by Burk, R. F.

Increased biliary GSSG efflux from rat livers perfused with thiocarbamide substrates for the flavin-containing monooxygenase

PA Krieter, DM Ziegler, KE Hill and RF Burk

Thiourea, phenylthiourea, and methimazole perfused into rat liver stimulated the biliary efflux of GSSG without affecting the excretion of GSH into either the bile or the caval perfusate. The thiocarbamide moiety appears essential, since perfusion with urea, phenylurea, or N- methylimidazole did not stimulate GSSG release. Hydrogen peroxide is also not an obligatory intermediate, since thiocarbamide-induced GSSG efflux was undiminished in livers from selenium-deficient animals. The response was also not affected by N-benzylimidazole, a potent cytochrome P-450 inhibitor, which suggests that this monooxygenase is not involved. However, the results are consistent with a model based on S-oxygenation of thiocarbamides to formamadine sulfenates catalyzed exclusively by the flavin-containing monooxygenase. The resulting sulfenate is reduced by GSH, yielding GSSG and the parent thiocarbamide. Rapid cellular oxidation of GSH by this mechanism leads to biliary efflux of the disulfide.

Volume 26, Issue 1, pp. 122-127, 07/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. A. Francois, C. R. Nishida, P. R. O. de Montellano, I. R. Phillips, and E. A. Shephard
Human Flavin-Containing Monooxygenase 2.1 Catalyzes Oxygenation of the Antitubercular Drugs Thiacetazone and Ethionamide
Drug Metab. Dispos., January 1, 2009; 37(1): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Kousba, R. Soll, S. Yee, and M. Martin
Cyclic Conversion of the Novel Src Kinase Inhibitor [7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-Oxide Metabolite by Flavin-Containing Monoxygenases and Cytochrome P450 Reductase
Drug Metab. Dispos., December 1, 2007; 35(12): 2242 - 2251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Nagahara and A. Katayama
Post-translational Regulation of Mercaptopyruvate Sulfurtransferase via a Low Redox Potential Cysteine-sulfenate in the Maintenance of Redox Homeostasis
J. Biol. Chem., October 14, 2005; 280(41): 34569 - 34576.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. K. Krueger, L. K. Siddens, S. R. Martin, Z. Yu, C. B. Pereira, E. T. Cabacungan, R. N. Hines, K. G. Ardlie, J. L. Raucy, and D. E. Williams
DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
Drug Metab. Dispos., December 1, 2004; 32(12): 1337 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
Wei Shen and B.-a. Hoener
Mitigation of nitrofurantoin-induced toxicity in the perfused rat liver
Human and Experimental Toxicology, May 1, 1996; 15(5): 428 - 434.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics